Neutrogena Stubborn Body Acne Cleanser and Exfoliator

Description

Neutrogena® Stubborn Body Acne Cleanser & Exfoliator is a dermatologist-recommended formulation designed for the treatment of body acne. This product contains salicylic acid, a well-known acne treatment, combined with polyhydroxy acid (PHA) to enhance exfoliation. It is fragrance-free, making it suitable for sensitive skin. The cleanser is presented in a liquid dosage form, with a volume of 8.5 fluid ounces (250 mL). The formulation gently exfoliates the skin, effectively clears existing breakouts, and aids in the prevention of future acne occurrences.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The product is intended for use on wet skin. Healthcare professionals should instruct patients to gently massage the product over the body for a duration of 20 to 30 seconds. Following the massage, it is essential to rinse the product thoroughly from the skin and then pat dry. This product is recommended for daily use to achieve optimal results.

Contraindications

Use of this product is contraindicated in the following situations:

Contact with the eyes should be strictly avoided. In the event of contact, immediate flushing with water is required to mitigate potential harm.

Concurrent use with other topical acne medications is not recommended, as this may increase the likelihood of skin irritation and dryness. If irritation occurs, it is advised to limit use to one topical acne medication at a time.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes; in the event of contact, the affected area should be flushed immediately with water to mitigate potential irritation.

The concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. To minimize the risk of adverse effects, it is recommended that only one topical acne medication be used at a time.

This product should be kept out of reach of children to prevent accidental ingestion. In the case of swallowing the product, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware that it is for external use only. Care should be taken to avoid contact with the eyes; in the event of contact, it is imperative to flush the eyes immediately with water.

Skin irritation and dryness are common adverse reactions associated with the use of this product, particularly if it is used concurrently with another topical acne medication. To minimize the risk of irritation, it is recommended that patients use only one topical acne medication at a time.

In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center without delay.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Stubborn Body Acne Cleanser and Exfoliator (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may use Neutrogena Stubborn Body Acne Cleanser and Exfoliator; however, the drug insert does not provide specific information regarding geriatric use, dosage adjustments, safety concerns, or special precautions for this population.

Healthcare providers should exercise caution when recommending this product to geriatric patients, as the absence of data necessitates careful monitoring for any potential adverse effects. It is advisable to consider individual patient factors, including comorbidities and concurrent medications, when assessing the suitability of this product for elderly patients.

Pregnancy

There is no specific information regarding the use of Neutrogena Stubborn Body Acne Cleanser and Exfoliator during pregnancy. As such, safety concerns, dosage modifications, or special precautions for pregnant patients have not been established. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks and benefits of using this product during pregnancy.

Lactation

There is no specific information regarding the use of Neutrogena Stubborn Body Acne Cleanser and Exfoliator in lactating mothers or any lactation considerations provided in the drug insert. Therefore, the effects on breastfed infants and the excretion of the product in breast milk remain undetermined. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this product.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed to avoid contact with their eyes. If contact occurs, they should flush the eyes with water immediately to minimize irritation.

It is important to discuss the potential for skin irritation and dryness, particularly if patients are using another topical acne medication concurrently. Healthcare providers should recommend that if irritation occurs, patients should limit their use to one topical acne medication at a time to reduce the risk of adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted, ensuring straightforward management within standard storage conditions.

Additional Clinical Information

The product is administered topically and is recommended for daily use. Clinicians should advise patients to avoid contact with the eyes; in the event of contact, patients should immediately flush the area with water. It is important to note that the use of another topical acne medication concurrently may increase the likelihood of skin irritation and dryness. Therefore, if irritation occurs, patients should limit their use to one topical acne medication at a time.

Drug Information (PDF)

This file contains official product information for Neutrogena Stubborn Body Acne Cleanser and Exfoliator, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)